Atlas Trials

The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder

Clinical trial NCT05393921 · WITHDRAWN

Trial details

NCT number
NCT05393921
Sponsor
University Hospitals Cleveland Medical Center
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Benign Prostatic HyperplasiaOveractive Bladder
Start date
2026-06-01
Primary completion
2027-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.